Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
Concomitant Dry Eye in Patients With Ocular Allergy: an Under Recognized and Poorly Managed Syndrome
1 other identifier
observational
250
1 country
1
Brief Summary
Evaluating the percentage of patients that suffer from eye allergies and determining whether they also have dry eyes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 20, 2012
CompletedFirst Posted
Study publicly available on registry
September 5, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedJune 3, 2016
January 1, 2013
1.5 years
August 20, 2012
June 2, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of dry eye in an allergic population presenting to a high volume optometry practice
up to 2 years
Secondary Outcomes (1)
Prevalence of allergic patients with moderate to severe ocular signs and symptoms
up to 2 years
Study Arms (1)
Dry Eyes, Eye Allergies
Patients with ocular allergies and those with dry eyes.
Eligibility Criteria
Patients will be screened from existing patient database.
You may qualify if:
- Ability to give informed consent
- Males and females at least 18 years of age
- Personal history of allergic disorders including but not limited to allergic conjunctivitis, allergic rhinitis, contact dermatitis and other eczema, and asthma
- Diagnosis of allergic conjunctivitis
- Presence of any of the following signs including conjunctival redness and papillae, chemosis, red edematous eyelids, reduced tear clearance, reduced TBUT, vital staining, stringy discharge, and/or symptoms including ocular itching, burning and tearing, runny nose or itchy throat
You may not qualify if:
- Active ocular or systemic infection
- History of ocular infection within past 6 months
- Presence of punctal plugs
- Recent ocular surgery within past 6 months
- Current use of chemotherapeutic agents
- Presence of ocular trauma
- Inability to give informed consent
- Women who are pregnant, nursing or lactating
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Schwartz Laser Eye Centerlead
- Allergancollaborator
Study Sites (1)
Schwartz Laser Eye Center
Scottsdale, Arizona, 85260, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marc R Bloomenstein, O.D.
Schwartz Laser Eye Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- O.D.
Study Record Dates
First Submitted
August 20, 2012
First Posted
September 5, 2012
Study Start
August 1, 2012
Primary Completion
February 1, 2014
Study Completion
February 1, 2014
Last Updated
June 3, 2016
Record last verified: 2013-01